TJD-AD 2018-031 Disciplinary Decision - Athletics

Related case:

TJD-AD 2018-052 Appeal Decision - Athletics
June 6, 2018

The Brazilian Doping Control Authority (ABCD) has reported an anti-doping rule violation against the Athlete after his A and B samples tested positive for the prohibited substance Recombinant Human Erythropoietin (rhEPO).

Previously the Athlete was sanctioned for 2 months until December 2010 for the presence of Oxilofrine (methylsynephrine) and again sanctioned for 4 years until October 2016 for the presence of EPO.

After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Brazilian Sports Justice Anti-Doping Tribunal.

The Athlete denied the intentional use of the substance and asserted with evidence that he had used prescribed iron supplements as treatment for his condition.

The TJD-AD Panel finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation. Further the Panel considers that this is the Athlete's 3rd anti-doping rule violation and that there had been delays in the proceedings not attributed to the Athlete.

Therefore the TJD-AD Panel decides by majority on 13 March 2018 to impose a 30 year period of ineligibility on the Athlete, starting backdated on the date of the sample collection, i.e. on 9 June 2017.

Original document


Legal Source
National Decisions
13 March 2018
Souza, Marcel Ramon Ponikwar
Vieira, Robson Luiz
Original Source
Brazilian Sports Justice Anti-Doping Tribunal (TJD-AD)
Adverse Analytical Finding / presence
Legal Terms
Lifetime period of ineligibility
Majority opinion
Substantial delay / lapsed time limit
Third violation
Athletics (WA) - World Athletics
Other organisations
Autoridade Brasileira de Controle de Dopagem (ABCD) - Brazilian Doping Control Authority
Tribunal de Justiça Desportiva Antidopagem (TJD-AD) - Brazilian Sports Justice Anti-Doping Tribunal
Analytical aspects
B sample analysis
Doping classes
S2. Peptide Hormones, Growth Factors
Erythropoietin (EPO)
Document type
Pdf file
Date generated
14 July 2022
Date of last modification
4 August 2022
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period